GTCR Announces Sale of AssuredPartners to Arthur J. Gallagher & Co. for $13.45 Billion
Sale is the Culmination of Successful 13-year Relationship Between GTCR and AssuredPartners that Began as a Leaders Strategy™ Partnership with Insurance Industry Veteran Jim Henderson CHICAGO, Dec. 9, 2024 /PRNewswire/ — GTCR, a leading private equity firm, announced today that it has signed
Chorus One Joins Northstake’s ETH Validator Marketplace As Node Operator
The partnership will strengthen institutional confidence in Northstake’s solution with secure, scalable, and compliant infrastructure COPENHAGEN, Denmark, Dec. 9, 2024 /PRNewswire/ — Northstake A/S has announced that blockchain node infrastructure provider, Chorus One, will join its ETH
Simon® to Present at the Goldman Sachs 2024 U.S. Financial Services Conference
INDIANAPOLIS, Dec. 9, 2024 /PRNewswire/ — Simon®, a real estate investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations, announced today that the Company will present at the Goldman Sachs 2024 U.S. Financial Services Conference on Wednes
Lorena Cosmetics Holdings SPV Announces Acquisition and Re-Launch of The Harley Medical Group & sk:n Clinic Group
LONDON, Dec. 9, 2024 /PRNewswire/ –In a landmark move for the UK cosmetic, aesthetics and medical dermatology sector, Lorena Cosmetics Holdings SPV Limited has successfully acquired and re-launched the sk:n and The Harley Medical Group (THMG) aesthetic and cosmetic surgery clinic chains. Loren
U Power and Major Shareholder Chatchaval Jiaravanon Outline Strategic Collaboration for 2025
Third-generation member of Thailand’s Charoen Pokphand Group and Fortune magazine owner reinforces commitment to U Power’s innovative EV battery solutions SHANGHAI, Dec. 9, 2024 /PRNewswire/ — U Power Limited (the “Company” or “U Power”), today announced a s
Arthur J. Gallagher & Co. Announces $8.5 Billion Common Stock Offering
ROLLING MEADOWS, Ill., Dec. 9, 2024 /PRNewswire/ — Arthur J. Gallagher & Co. (NYSE: AJG) (“Gallagher”) today announced an underwritten public offering of $8.5 billion of its common stock. Morgan Stanley & Co. LLC is acting as lead active book-running manager and BofA Sec
Nuvalent Appoints Grant Bogle to Board of Directors
CAMBRIDGE, Mass., Dec. 9, 2024 /PRNewswire/ — Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the appointment of Grant Bogle to its Board of Directors.
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for pegunigalsidase alfa
Application to label a less frequent dosing regimen at a dose of 2 mg/kg body weight administered every four weeks in adult patients with Fabry disease in European Union PARMA, Italy and CARMIEL Israel, Dec. 9, 2024 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of the Chiesi Gro
Osage Advisors Advises Falcon Electronics in its Sale to Brevan Electronics
CENTERBROOK, Conn., Dec. 9, 2024 /PRNewswire/ — Osage Advisors (“Osage”), a leading Connecticut-based mergers and acquisitions firm, is pleased to announce the sale of its client, Falcon Electronics (“Falcon”) to Brevan Electronics (“Brevan”). Falcon Electr
VirnetX Announces New Chief Technical Officer
ZEPHYR COVE, Nev., Dec. 9, 2024 /PRNewswire/ — VirnetX Holding Corporation (NYSE: VHC) today announced that it has hired Dr. John Anthony Jamison as new VirnetX Chief Technical Officer (CTO). From May 1997 to January 2018, Dr. Jamison served as a Naval Intelligence Officer for numerous s